Detalhes bibliográficos
| Resumo: | Introduction: Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) are not considered disease-modifying drugs in hypertrophic cardiomyopathy (HCM) and their use is usually dependent on other clinical indications. Few data exist about the use of ACEI/ARB in HC in the real world, particularly in patients with intraventricular obstruction. Objective: In this study, we sought to determine the frequency of ACEI / ARB therapy in patients with HCM and the predictors for their use. |
|---|
| Autores principais: | Martins, E. |
|---|
| Outros Autores: | Lebreiro, A.; Sousa, C.; Leite, S.; Sousa, A.; Belo, A.; Brito, Dulce; Cardim, N. |
|---|
| Assunto: | Angiotensin-converting enzyme inhibitors Hypertrophic cardiomyopathy |
|---|
| Ano: | 2018 |
|---|
| País: | Portugal |
|---|
| Tipo de documento: | artigo |
|---|
| Tipo de acesso: | acesso aberto |
|---|
| Instituição associada: | Universidade de Lisboa |
|---|
| Idioma: | inglês |
|---|
| Origem: | Repositório da Universidade de Lisboa |
|---|